Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion
Medanta expanded its bed capacity by 20% during the year
Medanta expanded its bed capacity by 20% during the year
Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026
Global specialty pipeline accelerates growth
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
Subscribe To Our Newsletter & Stay Updated